COMMUNIQUÉS West-GlobeNewswire

ObsEva Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Business Update
09/03/2018
Pipeline Achievements in 2017 Included Progress with Three Phase 3 and Two Phase 2 Clinical Trials -Key 2018 Clinical Milestones Anticipated for All Three Development Compounds Lead Compound OBE2109 Endometriosis Phase [...]
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself
09/03/2018
FIT Biotech Oy Company release March 9, 2018 at 2.00 pm EET FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself FIT Biotech Oy's Board of Directors has [...]
MacroGenics to Present at Cowen Health Care Conference
09/03/2018
Rockville, MD, March 09, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Asterias Biotherapeutics to Report Fourth Quarter and Full Year 2017 Results on March 15, 2018
09/03/2018
FREMONT, Calif., March 09, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American:ST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated [...]
Trillium Therapeutics Reports Annual 2017 Financial and Operating Results
09/03/2018
Presented evidence of clinical activity and good tolerability from both TTI-621 trials at ASH Received FDA clearance to proceed with second clinical CD47 program, TTI-622 Cash and marketable securities of $81.8 million [...]
ChemoCentryx Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Highlights
09/03/2018
-- Phase III ADVOCATE trial of avacopan in treatment of ANCA vasculitis nears 75% of patient enrollment target as European Medicine Agency continues review process of Conditional Marketing Authorization application [...]
Anavex Life Sciences to Present at the 30th Annual ROTH Conference
09/03/2018
NEW YORK, March 09, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL ), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of [...]
R1 RCM Reports Fourth Quarter and Full Year 2017 Results
09/03/2018
CHICAGO, March 09, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced results for the three months [...]
Solon Eiendom ASA : Extraordinary general meeting
09/03/2018
Solon Eiendom ASA (OSE: SOLON), held an extraordinary general meeting at the company's offices in Olav Vs gate 5, 0161, Oslo, Norway on 09 March 2018. All proposals were resolved as presented in the notice convening the [...]
Fertin Pharma A/S is awarded another issued patent on one-layered compressed nicotine gum
09/03/2018
VEJLE, Denmark, March 09, 2018 (GLOBE NEWSWIRE) -- The market leading nicotine gum manufacturer, Fertin Pharma A/S, adds another milestone in the protection of compressed nicotine gum. While Fertin Pharma A/S has [...]
Proposed merger between Medical Prognosis Institute and Oncology Venture
09/03/2018
Hørsholm, Denmark - Medical Prognosis Institute A/S ("MPI") (Nasdaq First North Stockholm: MPI) and Oncology Venture Sweden AB (publ) ("Oncology Venture" or "OV") (AktieTorget: OV) today jointly announce that their [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
09/03/2018
REGULATED INFORMATION GHENT, Belgium, 9 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Global Blood Therapeutics Announces Pricing of Public Offering of 4,000,000 Shares of Common Stock
09/03/2018
SOUTH SAN FRANCISCO, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (Nasdaq: GBT ), a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing [...]
Vical Announces News Release and Conference Call Schedule for Fourth Quarter 2017 Financial Results
09/03/2018
SAN DIEGO, March 08, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq: VICL ) today announced that the company will report financial results for the three months ended December 31, 2017, before the opening of trading [...]
Pascal Announces Oversubscription of Financing
09/03/2018
VANCOUVER, British Columbia, March 08, 2018 (GLOBE NEWSWIRE) -- NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Pascal Biosciences, Inc. ("Pascal" or the "Company") (TSX [...]
Sorrento Therapeutics CEO Dr. Ji to Present at Roth Capital Partners 30th Annual Growth Stock Conference on 03/12/18
09/03/2018
SAN DIEGO, March 08, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) ("Sorrento"), announced today that it will present at Roth Capital Partners 30 th annual growth stock conference on 03/12/18 at 1 [...]
Xeris Pharmaceuticals, Inc. Completes $55 million In New Financing To Support Ready-To-Use Glucagon Development
09/03/2018
CHICAGO, IL, March 08, 2018 (GLOBE NEWSWIRE) -- CHICAGO, IL; March 8, 2018 (GLOBE NEWSWIRE) – Xeris Pharmaceuticals, Inc. (“Xeris”), a specialty pharmaceutical company leveraging its novel technology platforms to [...]
Alphatec Spine Disrupts Market with Acquisition of SafeOp Surgical, ~$50M Equity Financing, and Strategic Leadership Appointments
08/03/2018
Acquisition provides Alphatec most advanced automated neuromonitoring technology Private placement funded by senior leadership, new and existing investors Luiz Pimenta, MD, PhD, to assume role of Chief Medical Officer [...]
Alphatec Spine Reports Fourth Quarter and Full Year 2017 Financial Results
08/03/2018
CARLSBAD, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq: ATEC ), a provider of innovative spine surgery solutions with a mission to improve patient lives [...]

Pages